ArticlePloS one2025
Development of the core outcome set for herbal medicine treatment of lumbar disc herniation (COS-HM-LDH): A study protocol for a systematic review and a delphi survey.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLumbar Disc Herniation (LDH) is a common global musculoskeletal disorder that causes a significant socioeconomic burden. Nonsurgical interventions are the primary treatment; however, herbal medicines (HM) are gaining traction for their efficacy in managing LDH. Conversely, their integration into clinical settings is limited owing to inconsistencies in clinical trial methodologies, mainly stemming from a lack of standardized outcome measures. Our research, highlighting this gap, sought to develop a Core Outcome Set (COS) to consistently assess HM treatments for LDH in Korean medicine (KM) clinical institutions using a consensus-driven, multi-phased approach.
methodsThe development of the COS-HM-LDH involves four main phases: (1) a project management group (PMG) conducts a systematic review to curate an initial list of outcomes; (2) several Delphi survey rounds are administered to a selected panel of experts to validate and refine these outcomes; (3) KM clinicians are involved in a subsequent Delphi survey to further refine the outcomes; and (4) a final consensus meeting finalizes the COS. DISCUSSION: The lack of a standardized COS for HM treatment of LDH in KM introduces biases and discrepancies in clinical practice. The proposed COS aims to provide a unified framework, given the challenges faced in clinical trials, especially in KM institutions. This initiative is expected to strengthen evidence quality, foster greater trust, and facilitate wider clinical implementation of HM treatment for LDH.
trial registrationThe Core Outcome Measures in Effectiveness Trials (COMET) Initiative: https://www.comet-initiative.org/Studies/Details/2909.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.